Communication autocrine : Questions médicales fréquentes
Nom anglais: Autocrine Communication
Descriptor UI:D019898
Tree Number:G04.085.100
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Communication autocrine : Questions médicales les plus fréquentes",
"headline": "Communication autocrine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Communication autocrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-27",
"dateModified": "2025-04-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Communication autocrine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Communication cellulaire",
"url": "https://questionsmedicales.fr/mesh/D002450",
"about": {
"@type": "MedicalCondition",
"name": "Communication cellulaire",
"code": {
"@type": "MedicalCode",
"code": "D002450",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G04.085"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Communication autocrine",
"alternateName": "Autocrine Communication",
"code": {
"@type": "MedicalCode",
"code": "D019898",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mei Chen",
"url": "https://questionsmedicales.fr/author/Mei%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology and the USC-Norris Comprehensive Cancer Center, University of Southern California Keck Medical Centre, Los Angeles, CA, 90033, USA."
}
},
{
"@type": "Person",
"name": "Hamideh P Fallah",
"url": "https://questionsmedicales.fr/author/Hamideh%20P%20Fallah",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Sciences, University of Calgary, 2500 University Drive NW, Calgary, Alberta, T2N 1N4, Canada."
}
},
{
"@type": "Person",
"name": "Hamid R Habibi",
"url": "https://questionsmedicales.fr/author/Hamid%20R%20Habibi",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Sciences, University of Calgary, 2500 University Drive NW, Calgary, Alberta, T2N 1N4, Canada. Electronic address: Habibi@ucalgary.ca."
}
},
{
"@type": "Person",
"name": "Michael Downes",
"url": "https://questionsmedicales.fr/author/Michael%20Downes",
"affiliation": {
"@type": "Organization",
"name": "Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037."
}
},
{
"@type": "Person",
"name": "Ronald M Evans",
"url": "https://questionsmedicales.fr/author/Ronald%20M%20Evans",
"affiliation": {
"@type": "Organization",
"name": "Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "WNT4 overexpression and secretion in thymic epithelial tumors drive an autocrine loop in tumor cells",
"datePublished": "2022-07-29",
"url": "https://questionsmedicales.fr/article/35965500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fonc.2022.920871"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gold Nanorods Induce Endoplasmic Reticulum Stress and Autocrine Inflammatory Activation in Human Neutrophils.",
"datePublished": "2022-06-23",
"url": "https://questionsmedicales.fr/article/35737452",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsnano.2c03586"
}
},
{
"@type": "ScholarlyArticle",
"name": "Autocrine motility factor receptor promotes the malignancy of glioblastoma by regulating cell migration and invasion.",
"datePublished": "2023-09-13",
"url": "https://questionsmedicales.fr/article/37703903",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01616412.2023.2257463"
}
},
{
"@type": "ScholarlyArticle",
"name": "Autocrine pro-legumain promotes breast cancer metastasis via binding to integrin αvβ3.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35854065",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41388-022-02409-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fatty Acid Signaling Impacts Prostate Cancer Lineage Plasticity in an Autocrine and Paracrine Manner.",
"datePublished": "2022-07-15",
"url": "https://questionsmedicales.fr/article/35884514",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cancers14143449"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques cellulaires",
"item": "https://questionsmedicales.fr/mesh/D002468"
},
{
"@type": "ListItem",
"position": 3,
"name": "Communication cellulaire",
"item": "https://questionsmedicales.fr/mesh/D002450"
},
{
"@type": "ListItem",
"position": 4,
"name": "Communication autocrine",
"item": "https://questionsmedicales.fr/mesh/D019898"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Communication autocrine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Communication autocrine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Communication autocrine",
"description": "Comment diagnostiquer une communication autocrine ?\nQuels tests sont utilisés pour évaluer la communication autocrine ?\nY a-t-il des marqueurs spécifiques pour la communication autocrine ?\nLa communication autocrine est-elle visible par imagerie ?\nQuels sont les signes d'une dérégulation autocrine ?",
"url": "https://questionsmedicales.fr/mesh/D019898?page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Communication autocrine",
"description": "Quels symptômes indiquent une communication autocrine anormale ?\nLa communication autocrine affecte-t-elle le métabolisme ?\nY a-t-il des symptômes spécifiques liés à l'autocrine dans le cancer ?\nComment la communication autocrine influence-t-elle l'immunité ?\nDes symptômes neurologiques peuvent-ils être liés à l'autocrine ?",
"url": "https://questionsmedicales.fr/mesh/D019898?page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Communication autocrine",
"description": "Comment prévenir les dérégulations autocrines ?\nY a-t-il des mesures préventives spécifiques pour le cancer ?\nL'exercice physique aide-t-il à réguler l'autocrine ?\nLe stress influence-t-il la communication autocrine ?\nDes compléments alimentaires peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D019898?page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Communication autocrine",
"description": "Quels traitements ciblent la communication autocrine ?\nLes médicaments peuvent-ils moduler la communication autocrine ?\nY a-t-il des traitements spécifiques pour le cancer liés à l'autocrine ?\nComment la thérapie génique influence-t-elle l'autocrine ?\nLes traitements hormonaux affectent-ils la communication autocrine ?",
"url": "https://questionsmedicales.fr/mesh/D019898?page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Communication autocrine",
"description": "Quelles complications peuvent résulter d'une communication autocrine anormale ?\nLa communication autocrine peut-elle entraîner des troubles métaboliques ?\nY a-t-il des risques d'inflammation chronique ?\nComment la communication autocrine affecte-t-elle le cancer ?\nDes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D019898?page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Communication autocrine",
"description": "Quels sont les facteurs de risque de dérégulation autocrine ?\nL'alimentation influence-t-elle la communication autocrine ?\nLe stress est-il un facteur de risque ?\nY a-t-il des prédispositions génétiques ?\nL'exposition à des produits chimiques est-elle un risque ?",
"url": "https://questionsmedicales.fr/mesh/D019898?page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une communication autocrine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests biologiques et des analyses de signalisation cellulaire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la communication autocrine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture cellulaire et des dosages de cytokines peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour la communication autocrine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme les récepteurs de cytokines peuvent indiquer une communication autocrine."
}
},
{
"@type": "Question",
"name": "La communication autocrine est-elle visible par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle n'est généralement pas visible par imagerie, mais des techniques avancées peuvent aider."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une dérégulation autocrine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent une croissance cellulaire anormale ou une inflammation persistante."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une communication autocrine anormale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes peuvent inclure des douleurs, des inflammations ou des tumeurs."
}
},
{
"@type": "Question",
"name": "La communication autocrine affecte-t-elle le métabolisme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut influencer le métabolisme cellulaire et provoquer des déséquilibres."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques liés à l'autocrine dans le cancer ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fatigue et la perte de poids peuvent être présents."
}
},
{
"@type": "Question",
"name": "Comment la communication autocrine influence-t-elle l'immunité ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut moduler la réponse immunitaire, entraînant une inflammation ou une immunosuppression."
}
},
{
"@type": "Question",
"name": "Des symptômes neurologiques peuvent-ils être liés à l'autocrine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en raison de la signalisation autocrine."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dérégulations autocrines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir ces dérégulations."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques pour le cancer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les carcinogènes et maintenir un poids santé sont des mesures préventives."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à réguler l'autocrine ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler la signalisation autocrine et améliorer la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la communication autocrine ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la communication autocrine et affecter la santé."
}
},
{
"@type": "Question",
"name": "Des compléments alimentaires peuvent-ils aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains compléments, comme les oméga-3, peuvent moduler la communication autocrine."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent la communication autocrine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des inhibiteurs de signalisation peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils moduler la communication autocrine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent inhiber ou stimuler la signalisation autocrine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques pour le cancer liés à l'autocrine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme les anticorps monoclonaux ciblent souvent la communication autocrine dans le cancer."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique influence-t-elle l'autocrine ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique peut corriger des dérégulations dans la communication autocrine."
}
},
{
"@type": "Question",
"name": "Les traitements hormonaux affectent-ils la communication autocrine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements hormonaux peuvent influencer la signalisation autocrine dans certaines pathologies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une communication autocrine anormale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des cancers, des maladies auto-immunes et des inflammations chroniques."
}
},
{
"@type": "Question",
"name": "La communication autocrine peut-elle entraîner des troubles métaboliques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dérégulation peut provoquer des troubles métaboliques comme le diabète."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'inflammation chronique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une communication autocrine anormale peut entraîner une inflammation chronique."
}
},
{
"@type": "Question",
"name": "Comment la communication autocrine affecte-t-elle le cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut favoriser la croissance tumorale et la résistance aux traitements anticancéreux."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dérégulations peuvent entraîner des troubles neurologiques et cognitifs."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de dérégulation autocrine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'obésité, le tabagisme et l'exposition à des toxines."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la communication autocrine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en sucres et graisses peut perturber la signalisation autocrine."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter le risque de dérégulation autocrine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mutations génétiques peuvent prédisposer à des dérégulations autocrines."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques est-elle un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques toxiques peut augmenter le risque de dérégulation."
}
}
]
}
]
}
WNT4-driven non-canonical signaling is crucial for homeostasis and age-related involution of the thymus. Abnormal WNT signaling is important in many cancers, but the role of WNT signaling in thymic tu...
Expression and function of WNT4 and FZD6 were analyzed using qRT-PCR, Western blot, ELISA, in biopsies of non-neoplastic thymi (NT), thymoma and thymic carcinomas. ShRNA techniques and functional assa...
In biopsy, WHO classified B3 thymomas and TCs showed increased WNT4 expression compared with NTs. During short-term 2D culture, WNT4 expression and secretion declined in neoplastic pTECs but not in 3D...
Lack of the age-related decline of non-canonical WNT4 expression in TETs and restoration of declining WNT4 expression through exogeneous WNT4 or 3D culture of pTECs hints at an oncogenic role of WNT4 ...
Gold nanorods (AuNRs) are promising agents for diverse biomedical applications such as drug and gene delivery, bioimaging, and cancer treatment. Upon in vivo application, AuNRs quickly interact with c...
One of the important causes of death in cancer patients is malignant metastasis, invasion, and metastasis of tumor cells. Metastasis is also the most basic physiological characteristics and pathogenes...
In order to study the role of AMFR in the cell migration and invasion of glioblastoma, AMFR was silenced using siRNA and overexpressed using cDNA. Immunoblotting analysis and real-time quantitative po...
This study found that the level of AMFR expression was significantly correlated with the malignant degree of glioma tissue in clinic samples. AMFR silencing decreased cell migration and invasion of LN...
This study suggests that AMFR could be used as a therapeutic strategy for the clinical treatment of glioblastoma....
Tumor metastasis is the leading cause of cancer-associated mortality. Unfortunately, the underlying mechanism of metastasis is poorly understood. Expression of legumain (LGMN), an endo-lysosomal cyste...
Prostate cancer (PCa) affects an estimated 250,000 men every year and causes 34,000 deaths annually. A high-fat diet and obesity are associated with PCa progression and mortality. This study's premise...
High-grade serous ovarian carcinoma (HGSOC) is genetically unstable and characterised by the presence of subclones with distinct genotypes. Intratumoural heterogeneity is linked to recurrence, chemoth...
Thyroid stimulating hormone (TSH), a glycoprotein synthesized and secreted from thyrotrophs of the pituitary gland, is composed of a glycoprotein hormone common alpha subunit (CGA) and a specific beta...
Lymph node metastasis (LNM) is the main metastatic pathway of cervical cancer, which is closely related to 5-year survival rate of cervical squamous cell carcinoma (CSCC), yet the underlying mechanism...
Hepatic fibrosis is characterized by enhanced deposition of extracellular matrix (ECM), which results from the wound-healing response to chronic, repeated injury of any etiology. Upon injury, hepatic ...
We analyzed MCPIP1 levels in patients' fibrotic livers and hepatic cells isolated from fibrotic murine livers. In vitro experiments were conducted on primary HSCs, cholangiocytes, hepatocytes and LX-2...
MCPIP1 levels are induced in patients' fibrotic livers compared to their nonfibrotic counterparts. Murine models of fibrosis revealed that its level is increased in HSCs and hepatocytes. Moreover, hep...
We demonstrated that MCPIP1 is induced in human fibrotic livers and regulates the activation of HSCs in both autocrine and paracrine manners. Our results indicate that MCPIP1 could have a potential ro...
Cancer cell metabolism contributes to the establishment of an immunosuppressive tumor microenvironment. Aberrant expression of CD73, a critical enzyme in ATP metabolism, on the cell surface results in...